Premenstrual Dysphoric Disorder: Contemporary Diagnosis and Management

Area of Science:

• Gynecology
• Psychiatry
• Pharmacology

Background:

• Most women experience mild premenstrual symptoms (PMS) with little clinical impact.
• A subset of women develops severe physical and psychological premenstrual symptoms, impacting quality of life and relationships.
• The exact cause of severe premenstrual syndrome and premenstrual dysphoric disorder remains unclear, though research is ongoing.

Purpose of the Study:

• To review current understanding and treatment of premenstrual dysphoric disorder (PMDD) and severe premenstrual syndrome (PMS).
• To highlight the importance of accurate diagnosis for effective therapeutic selection.
• To discuss available and emerging treatment options for women with impairing premenstrual symptoms.

Main Methods:

• Review of current literature on premenstrual symptom etiology, diagnosis, and treatment.
• Analysis of pharmacotherapeutic options, including SSRIs, SNRIs, and hormonal suppressants.
• Evaluation of non-pharmacological interventions like cognitive behavioral therapy (CBT).

Main Results:

• Refined diagnostic criteria improve differentiation from other psychiatric conditions.
• Selective serotonin reuptake inhibitors (SSRIs) and SNRIs are first-line treatments for PMDD and severe PMS.
• Medical ovarian suppression is an option for treatment-resistant cases, while CBT shows promise but faces access limitations.

Conclusions:

• Accurate diagnosis is critical for managing premenstrual dysphoric disorder and severe premenstrual syndrome.
• Pharmacotherapy is the primary treatment approach, with hormonal suppression for refractory cases.
• Further research and improved access to therapies like CBT are needed for comprehensive patient care.